Results 241 to 250 of about 522,586 (301)

Mapping antimicrobial susceptibility of community-acquired uropathogenic Escherichia coli across low, middle and high-income countries highlights significant differences: insights for empiric treatment. [PDF]

IJID Reg
Rizvi M, Khan M, Al-Jardani A, Al-Abri SS, Ghoshal U, Jabri ZA, Ahanjan M, Mamari AA, Shizawi NA, Sami H, Balkhair A, Shaukat A, Alkharusi ANS, Almahrouqi A, Hassan A, Kumar A, Malehi AS, Gul A, Singh A, Shidhani ASHA, Siddiqui AH, Poojary A, Rashdi AA, Langford B, Stepanskyi D, Dolatabadi A, Maani AA, Mufarji AA, AlRisi ESA, Kapoor G, Princess I, Lawati HJA, Eltahir HA, Sidairi HA, Iskandar K, Masters K, Al-Busaidi IKH, Yazidi LA, Nasrin M, Subhi MSA, Sengupta M, Khandait M, Tamtami NKA, Siyabi NKA, Kindi NA, Luthfee NM, Shreshtha N, Riyami NMAA, Busaidi NHAA, Goel N, Ishchenko O, Taher OMEA, Jena PP, Ekadashi R, Al Zadjali R, Kanungo R, Abolghasemi S, Maqbali SA, Banerjee S, Yaqoob S, Sali S, Khan SH, Malhotra S, Hughes S, Shaukat S, Atif SM, Patwardhan VV, Dougnon V, Khan W, Wali W, Muharrmi ZA, Basit Z, Choudhury J, Pravalina R, John KHS, Singh S, Singh S, Taneja N, Sardana R, Ghafur A, Kapoor P, Soman R, Abri RA.   +82 more
europepmc   +1 more source

Suppression of virulence factors of uropathogenic Escherichia coli by Trans-resveratrol and design of nanoemulgel. [PDF]

BMC Microbiol
ElFeky DS, Kassem AA, Moustafa MA, Assiri H, El-Mahdy AM.   +4 more
europepmc   +1 more source

Current Insights into Antibiotic Resistance in Uropathogenic <i>Escherichia coli</i> and Interventions Using Selected Bioactive Phytochemicals. [PDF]

Antibiotics (Basel)
Futoma-Kołoch B, Sarowska J, Abd El-Salam M, Miñana-Galbis D, Drabová B, Guz-Regner K, Wiśniewska P, Kryniewska V.   +7 more
europepmc   +1 more source

Investigating the potential therapeutic compounds of Equisetum ramosissimum Desf. against uropathogenic Escherichia coli through molecular docking, MD simulation, ADMET and toxicity predictions

Jeyalatchagan Sureshkumar, Singamoorthy Amalraj, Govidaraju Varadharaju, Srinivasan Prabhu, Muniappan Ayyanar   +4 more
openalex   +1 more source

pH-dependent efficacy of nitrofurantoin against uropathogenic <i>Escherichia coli</i>: Implications for personalized urinary tract infection treatment. [PDF]

Indian J Urol
Mukhopadhyay A, Kumar D, Rain Z, Rai S, Singh S, Prakash P.   +5 more
europepmc   +1 more source

The role of uropathogenic <i>Escherichia coli</i> virulence factors in the development of urinary tract infection. [PDF]

J Med Life
Gebremedhin KB, Amogne W, Alemayehu H, Bopegamage S, Eguale T.   +4 more
europepmc   +1 more source

Immunogenic Potential of a Multi-Peptide Vaccine Construct Against Uropathogenic Escherichia coli-Associated Urinary Tract Infection. [PDF]

Iran Biomed J
Mirsharifi S, Habibi M, Rahimi T, Foroohi F, Asadi Karam MR.   +4 more
europepmc   +1 more source

Characterization of bacteriophages infecting multidrug-resistant uropathogenic Escherichia coli strains. [PDF]

Arch Virol
Markusková B, Elnwrani S, Andrezál M, Sedláčková T, Szemes T, Slobodníková L, Kajsik M, Drahovská H.   +7 more
europepmc   +1 more source

Exploring the antimicrobial activity of pantothenamides against uropathogenic <i>Escherichia coli</i>. [PDF]

Microbiol Spectr
DeColli AA, Meyers DJ, Ranjit A, Paule J, Serrano-Diaz E, Bockley KM, Ensign LM, Rais R, Freel Meyers CL.   +8 more
europepmc   +1 more source

An mRNA-based FimH nanoparticle vaccine against uropathogenic <i>Escherichia coli</i> is highly immunogenic in rodents. [PDF]

Front Immunol
Roier S, Adamo R, Rosini R, Pezzicoli A, Scarselli M, Petsch B, Jasny E, Rauch S.   +7 more
europepmc   +1 more source